Open-access systematic review of preclinical fasting-mimicking diet studies in cancer models. It summarizes evidence that FMD can alter tumor metabolism and may enhance chemotherapy, hormone therapy, targeted therapy, immunotherapy, or vitamin C effects in animal studies, while emphasizing that the evidence base is primarily preclinical.
Immunotherapy
Immunotherapy is a conventional oncology treatment or care pathway used within standard cancer care, usually under the direction of oncology specialists and with disease-specific indications. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct, or an alternative claim.
Mayo Clinic patient education page covering diagnostic tests, staging, surgery, chemotherapy, radiation, immunotherapy, clinical trials, and palliative care for pancreatic cancer.
Chapter focused on fever-range whole-body hyperthermia, water-filtered infrared-A irradiation, immunotherapy-era rationale, and limitations of the clinical evidence.
Critical overview revisiting Yamamoto GcMAF research and debate around retracted studies.
Retraction notice for the metastatic colorectal cancer GcMAF paper.
Retraction notice for Yamamoto metastatic breast cancer GcMAF paper.
Anticancer Fund letter identifying serious inconsistencies and reliability problems in Yamamoto GcMAF cancer evidence.
Small uncontrolled prostate cancer report claiming nagalase normalization and long recurrence-free follow-up.
Retracted Yamamoto paper claiming eradication of metastatic colorectal cancer based on nagalase normalization.
Retracted Yamamoto paper claiming metastatic breast cancer responses after weekly GcMAF and nagalase decline.
Mouse SCCVII tumor model study of DBP-MAF as an adjunct to photodynamic therapy.
NCI patient summary covering diagnosis, treatment phases, chemotherapy, targeted therapy, immunotherapy, stem cell transplant, and follow-up for acute lymphoblastic leukemia.
Open-access review of adenoid cystic carcinoma current therapy, recurrence, metastasis, genomics, targeted therapy, and emerging immune-based approaches.
NCI patient summary about adrenocortical carcinoma diagnosis, staging, surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.
Active NCI-listed trial assessing FMD for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
NCI-listed pilot phase II trial record for fasting-mimicking diet with chemo-immunotherapy in metastatic non-small cell lung cancer. The listing describes the hypothesis that FMD may enhance cancer-cell vulnerability and reduce treatment side effects.
NCI PDQ patient summary covering melanoma diagnosis, staging, surgery, immunotherapy, targeted therapy, and clinical trials.
Disease-aware source pass harvested this article while searching for Esophageal Cancer. Review title, author, date, and summary before relying on this record.
Automatically harvested from the article source list. Review title, date, author, source and summary before relying on this record.
Open-access review of current management of alveolar soft part sarcoma, including surgery, radiotherapy, chemotherapy controversy, targeted agents, and checkpoint inhibitors.
NCI treatment-type overview placing chemotherapy among surgery, radiation, immunotherapy, targeted therapy, hormone therapy, hyperthermia, and stem cell transplant.